As China’s Stock Market Crashed, These Hedge Funds Rose 70%

Posted by & filed under Economic Analysis, Growth & Valuation.

Description: China’s summer market selloff wasn’t a total rout if you were one of the country’s top-performing hedge funds that gained an average 70 percent as almost 1,300 other funds were wiped out. Source: Bloomberg.com – video report Date: Oct 29, 2015 Link: http://www.bloomberg.com/news/articles/2015-10-29/as-china-s-stock-market-crashed-these-hedge-funds-returned-70- Questions for Discussions: Summarize who won and who lost in China,… Read more »

How snacking is helping this company thrive in today’s global economy

Posted by & filed under Company Analysis, Economic Analysis, Financial Planning.

Description: Irene Rosenfeld, CEO of Mondelez International, sits down with Fortune’s Susie Gharib and discusses how the global trend to snack is helping the food conglomerate. Source: Fortune.com – video report Date: Oct 29, 2015 Link: http://for.tn/1NaLPBU Questions for discussion: How has management at Mondelez responded to global challenges, in terms of “controls”? Why would… Read more »

Opinion: These 3 big stocks with earnings power are strong buys

Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation.

Description: Alphabet, McDonald’s, GM do not disappoint Source: MarketWatch.com Date: Oct 29, 2015 Link: http://www.marketwatch.com/story/these-3-big-stocks-with-earnings-power-are-strong-buys-2015-10-30?dist=lcountdown Questions for Discussions: What is the financial basis for buying these stocks? Do you agree with the assessments?

The Trouble With Saving 21 Trillion Yuan

Posted by & filed under Economic Analysis, Growth & Valuation.

Description: China’s public institutions stuff their cash in banks. Source: Bloomberg.com Date: Oct 29, 2015 Link: http://www.bloomberg.com/news/articles/2015-10-29/china-s-trouble-with-saving-21-trillion-yuan Questions for discussion: Summarize the concerns raised in this article? How should investors outside of China deal with this assessment?

Bill Ackman’s Defense Of Valeant Pharmaceuticals Takes Long View On Drugmaker’s Woes

Posted by & filed under Financial Planning, Growth & Valuation, Market Analysis.

Description: Pershing Square’s Bill Ackman wasn’t able to convince Wall Street once and for all whether embattled drugmaker Valeant Pharmaceuticals can recover from its woes or will continue heading south. Source: Forbes.com Date: Oct 30, 2015 Link: http://www.forbes.com/sites/antoinegara/2015/10/30/bill-ackmans-defense-of-valeant-pharmaceuticals-takes-long-view-on-drugmakers-woes/ Questions for discussion: What does the article say about Bill Ackman’s strategic thinking? Do you agree?